iShares LifePath Target Date 2045 ETF (NYSEARCA:ITDE) Shares Up 0.2% – What’s Next?

iShares LifePath Target Date 2045 ETF (NYSEARCA:ITDEGet Free Report) traded up 0.2% during trading on Tuesday . The stock traded as high as $36.59 and last traded at $36.50. 11,296 shares were traded during trading, an increase of 13% from the average session volume of 9,978 shares. The stock had previously closed at $36.42.

iShares LifePath Target Date 2045 ETF Stock Performance

The company has a market capitalization of $49.64 million, a PE ratio of 20.03 and a beta of 0.82. The firm’s 50-day simple moving average is $36.14 and its 200 day simple moving average is $34.69.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Geneos Wealth Management Inc. purchased a new position in iShares LifePath Target Date 2045 ETF in the first quarter valued at about $34,000. Susquehanna International Group LLP grew its holdings in shares of iShares LifePath Target Date 2045 ETF by 38.4% in the 3rd quarter. Susquehanna International Group LLP now owns 9,001 shares of the company’s stock worth $323,000 after acquiring an additional 2,496 shares during the period. Finally, Sunbelt Securities Inc. grew its holdings in shares of iShares LifePath Target Date 2045 ETF by 2,054.5% in the 3rd quarter. Sunbelt Securities Inc. now owns 2,607 shares of the company’s stock worth $94,000 after acquiring an additional 2,486 shares during the period.

iShares LifePath Target Date 2045 ETF Company Profile

(Get Free Report)

The iShares LifePath Target Date 2045 ETF USD (ITDE) is an exchange-traded fund that mostly invests in target date asset allocation. The fund is an actively managed fund-of-funds that invests in equity, fixed income, and money market ETFs using an asset allocation strategy that shifts exposure as the target retirement date approaches.

Further Reading

Receive News & Ratings for iShares LifePath Target Date 2045 ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares LifePath Target Date 2045 ETF and related companies with MarketBeat.com's FREE daily email newsletter.